OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
7823$810.0057

Artnature Inc

Personal ProductsVerified

Artnature Inc maintains a strong liquidity position, with a current ratio of 2.06 and cash and equivalents amounting to ¥18.16 billion, which represents 36.6% of total assets. The company has no long-term debt, and its debt-to-equity ratio is 0.0, indicating a conservative capital structure. The price-to-book ratio of 0.98 suggests that the company's market value is slightly below its book value, while the price-to-tangible-book ratio is also 0.98, reflecting a similar valuation dynamic. Profitability metrics show that Artnature Inc has a return on equity (ROE) of 3.04% and a return on assets (ROA) of 1.66%, both of which are below the typical thresholds for high-performing companies in the personal care products industry. The company's operating margin is 3.30% (calculated from operating income of ¥1.43 billion on revenue of ¥43.34 billion), and its net margin is 1.90% (net income of ¥823 million on revenue of ¥43.34 billion), indicating relatively modest profitability. Geographically, Artnature Inc's revenue is concentrated in Japan, as disclosed in its segments. The company does not report significant international operations, and its business is primarily focused on the domestic market. This concentration may expose the company to regional economic fluctuations and regulatory changes specific to Japan. The company's growth trajectory appears to be modest, with no significant revenue growth reported in the latest financial period. The company's free cash flow is negative at ¥1.52 billion, driven by capital expenditures of ¥2.59 billion, which suggests that the company is investing in its operations. However, the absence of long-term debt and the strong cash position provide flexibility for future growth initiatives. Risk factors for Artnature Inc include the potential for dilution, although the risk is currently assessed as low. The company has no immediate filing-based liquidity or dilution flags, and its capital structure is conservative. The absence of long-term debt reduces credit risk, but the company's reliance on domestic markets and modest profitability could pose challenges in a competitive environment. Recent events and disclosures indicate that Artnature Inc has not issued any significant new shares or taken on new debt in the latest reporting period. The company's latest actual EPS was 25.23 JPY, and its actual revenue was ¥43.34 billion, aligning with analyst estimates. No major regulatory or operational risks were disclosed in the latest filings.

30-day price · 7823-6.00 (-0.7%)
Low$801.00High$836.00Close$812.00As of16 May, 00:00 UTC
Profile
CompanyArtnature Inc
Ticker7823.T
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. Artnature Inc is a Japanese personal care products company that generates revenue through the production and sale of personal products, primarily in the consumer non-cyclicals sector.

Classification. Artnature Inc is classified under the industry "Personal Products" within the business sector "Personal & Household Products & Services" in the economic sector "Consumer Non-Cyclicals," with a confidence level of 0.92.

Artnature Inc maintains a strong liquidity position, with a current ratio of 2.06 and cash and equivalents amounting to ¥18.16 billion, which represents 36.6% of total assets. The company has no long-term debt, and its debt-to-equity ratio is 0.0, indicating a conservative capital structure. The price-to-book ratio of 0.98 suggests that the company's market value is slightly below its book value, while the price-to-tangible-book ratio is also 0.98, reflecting a similar valuation dynamic. Profitability metrics show that Artnature Inc has a return on equity (ROE) of 3.04% and a return on assets (ROA) of 1.66%, both of which are below the typical thresholds for high-performing companies in the personal care products industry. The company's operating margin is 3.30% (calculated from operating income of ¥1.43 billion on revenue of ¥43.34 billion), and its net margin is 1.90% (net income of ¥823 million on revenue of ¥43.34 billion), indicating relatively modest profitability. Geographically, Artnature Inc's revenue is concentrated in Japan, as disclosed in its segments. The company does not report significant international operations, and its business is primarily focused on the domestic market. This concentration may expose the company to regional economic fluctuations and regulatory changes specific to Japan. The company's growth trajectory appears to be modest, with no significant revenue growth reported in the latest financial period. The company's free cash flow is negative at ¥1.52 billion, driven by capital expenditures of ¥2.59 billion, which suggests that the company is investing in its operations. However, the absence of long-term debt and the strong cash position provide flexibility for future growth initiatives. Risk factors for Artnature Inc include the potential for dilution, although the risk is currently assessed as low. The company has no immediate filing-based liquidity or dilution flags, and its capital structure is conservative. The absence of long-term debt reduces credit risk, but the company's reliance on domestic markets and modest profitability could pose challenges in a competitive environment. Recent events and disclosures indicate that Artnature Inc has not issued any significant new shares or taken on new debt in the latest reporting period. The company's latest actual EPS was 25.23 JPY, and its actual revenue was ¥43.34 billion, aligning with analyst estimates. No major regulatory or operational risks were disclosed in the latest filings.
Key takeaways
  • Artnature Inc has a strong liquidity position with no long-term debt and a current ratio of 2.06.
  • The company's profitability is modest, with ROE of 3.04% and ROA of 1.66%.
  • Revenue is concentrated in Japan, which may expose the company to regional economic risks.
  • Free cash flow is negative due to capital expenditures, but the company's cash position provides flexibility.
  • The risk of dilution is low, and the company has no immediate liquidity or dilution flags.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$43.34B
Gross profit$28.69B
Operating income$1.43B
Net income$823.0M
R&D
SG&A
D&A
SBC
Operating cash flow$2.58B
CapEx-$2.59B
Free cash flow-$1.52B
Total assets$49.68B
Total liabilities$22.63B
Total equity$27.04B
Cash & equivalents$18.16B
Long-term debt$0.00
Valuation
Market price$810.00
Market cap$26.39B
Enterprise value$8.23B
P/E32.1
Reported non-GAAP P/E
EV/Revenue0.2
EV/Op income5.8
EV/OCF3.2
P/B1.0
P/Tangible book1.0
Tangible book$27.04B
Net cash$18.16B
Current ratio2.1
Debt/Equity0.0
ROA1.7%
ROE3.0%
Cash conversion3.1%
CapEx/Revenue-6.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Personal Products · cohort 185 companies
Metric7823Activity
Op margin3.3%6.0% medp25 0.5% · p75 12.6%below median
Net margin1.9%5.2% medp25 0.5% · p75 10.9%below median
Gross margin66.2%43.2% medp25 26.0% · p75 61.0%top quartile
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-6.0%-3.0% medp25 -5.5% · p75 -1.3%bottom quartile
Debt / equity0.0%13.3% medp25 2.5% · p75 55.2%bottom quartile
Observations
IR observations
Last actual EPS25.23 JPY
Last actual revenue43,340,000,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 15:58 UTC#071ef087
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 03:26 UTCJob: 13a98edf